Is Green Thumb stock oversold? The case for 100% upside.
It’s a rare gem among marijuana stocks, for several reasons.
The Easiest Way to Bet on US Cannabis Is This One ETF
One ETF promises investors a clean shot at the U.S. cannabis trade, but the inside of this fund is stranger than its simple ticker suggests.
DEA Rescheduling Hearing Puts Cannabis Stocks in Focus Ahead of a July 15 Deadline
The DEA’s cannabis rescheduling hearing runs through a July 15 deadline, putting cannabis stocks and the MSOS ETF in focus.
Innovative Industrial Properties: Cannabis Rescheduling Progress Reinforces The Re-Rating Thesis
Innovative Industrial’s AFFO was stable at $1.88/share, and leverage is still low for a REIT. Click here to read why IIPR stock is a Strong Buy.
3 reasons to buy Green Thumb Industries stock hand over fist
Green Thumb continues to execute while competitors struggle.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Tilray’s stock is down over 50% this year. Has it become a bargain buy?
The cannabis stock recently hit a new 52-week low.
Is Green Thumb stock oversold? The case for 100% upside.
It’s a rare gem among marijuana stocks, for several reasons.
The Easiest Way to Bet on US Cannabis Is This One ETF
One ETF promises investors a clean shot at the U.S. cannabis trade, but the inside of this fund is stranger than its simple ticker suggests.
DEA Rescheduling Hearing Puts Cannabis Stocks in Focus Ahead of a July 15 Deadline
The DEA’s cannabis rescheduling hearing runs through a July 15 deadline, putting cannabis stocks and the MSOS ETF in focus.
Jim Cramer on Trulieve Cannabis: “I Think It’s a Terrific Spec”
Trulieve Cannabis Corp. (NYSE:TRLV) was among the stocks on which Jim Cramer commented, as he emphasized that SpaceX investors are betting on Elon Musk rather than the company’s earnings. A caller …
Tilray Looks Cheap On The Surface, But Shareholders Still Need Proof
Tilray Brands is rated Hold, trading at a discounted 0.5–0.6x P/S due to persistent unprofitability and dilution risk. Learn more about TLRY stock here.
The 5-minute investor podcast, ep. 65: Cannabis stocks cultivating alpha
Welcome to episode 65 of The 5-Minute Investor Podcast, where Stockhouse columnists Jonathon Brown and me, Trevor Abes, each deliver a 2.5-minute profile on a stock related to recent investment news.
The First U.S. Marijuana Stock Is Now Trading on the NYSE. Here’s What That Means for Every Cannabis Investor.
Last week, Trulieve Cannabis (OTC: TCNNF) (NYSE:TRLV) became the first U.S. cannabis operator to list on the New York Stock Exchange. The stock is now trading under the symbol “TR …
Aurora Cannabis Q4 Earnings Call Highlights
Aurora Cannabis (NASDAQ:ACB) reported a stronger fiscal 2026 performance than it had forecast, driven by growth in global medical cannabis, while warning that fiscal 2027 will be a “reset year” as …
Recent Comments